Secondary Hyperaldosteronism – Causes and Treatment
Secondary hyperaldosteronism is a condition in which the body produces too much aldosterone, triggered by an external cause such as kidney disease or heart failure.
Things worth knowing about "Secondary Hyperaldosteronism"
Secondary hyperaldosteronism is a condition in which the body produces too much aldosterone, triggered by an external cause such as kidney disease or heart failure.
What is Secondary Hyperaldosteronism?
Secondary hyperaldosteronism is a disorder in which the adrenal cortex produces excessive amounts of the hormone aldosterone. Unlike primary hyperaldosteronism, the underlying cause does not originate within the adrenal gland itself but rather externally – most commonly through dysregulation of the renin-angiotensin-aldosterone system (RAAS). This system regulates blood pressure and the body´s salt and water balance.
Causes
Secondary hyperaldosteronism develops due to elevated renin secretion from the kidneys, which in turn stimulates aldosterone production. Common triggers include:
- Heart failure: The heart pumps insufficient blood, causing the kidneys to perceive a low blood pressure and activate the RAAS.
- Liver cirrhosis: Chronic liver disease leading to fluid accumulation and altered hormonal regulation.
- Nephrotic syndrome: A kidney disorder characterized by excess protein loss in the urine and reduced blood volume.
- Renovascular hypertension: Narrowing of the renal arteries (e.g., due to atherosclerosis), prompting the kidneys to release increased amounts of renin.
- Chronic volume depletion: For example, from prolonged diuretic use, persistent diarrhea, or severe vomiting.
- Pregnancy: Physiologically elevated aldosterone levels during pregnancy may be further increased in some conditions.
Symptoms
Symptoms of secondary hyperaldosteronism arise from the effects of excess aldosterone on the body´s mineral balance:
- High blood pressure (hypertension): A frequent and central symptom.
- Hypokalemia: Low blood potassium levels, which can lead to muscle weakness, fatigue, cramps, and cardiac arrhythmias.
- Edema: Fluid retention in tissues, particularly in the legs and ankles.
- Polyuria and polydipsia: Increased urination and excessive thirst.
- General weakness and fatigue.
Diagnosis
Diagnosing secondary hyperaldosteronism requires a combination of laboratory tests and imaging studies:
- Blood tests: Measurement of aldosterone and renin levels in the blood. In secondary hyperaldosteronism, both values are elevated (in contrast to primary hyperaldosteronism, where renin is suppressed).
- Aldosterone-to-renin ratio (ARR): The ratio of these two hormones helps differentiate between primary and secondary hyperaldosteronism.
- Electrolyte panel: Detection of low potassium levels (hypokalemia).
- Imaging: Ultrasound, CT, or MRI to evaluate the kidneys, adrenal glands, liver, and heart in order to identify the underlying cause.
- Urine analysis: Measurement of aldosterone excretion in a 24-hour urine collection.
Treatment
Treatment of secondary hyperaldosteronism is primarily directed at the underlying cause:
Treatment of the Underlying Condition
When the triggering disease – such as heart failure, liver cirrhosis, or renal artery stenosis – is successfully managed, aldosterone overproduction often normalizes as well.
Pharmacological Therapy
- Aldosterone antagonists (e.g., spironolactone, eplerenone): Block the effects of aldosterone at its receptors, lowering blood pressure and reducing potassium loss.
- ACE inhibitors or AT1 receptor blockers (ARBs): These medications interfere with the RAAS and help reduce aldosterone production.
- Potassium supplementation: Administered when potassium levels are significantly low.
Interventional or Surgical Approaches
In cases of renovascular hypertension caused by renal artery stenosis, balloon dilation (angioplasty) or surgical repair of the narrowed artery may be considered.
References
- Funder JW et al. - The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 2016.
- Williams GH - Aldosterone biosynthesis, regulation, and classical mechanism of action. Heart Failure Reviews, 2005.
- Young WF - Primary aldosteronism: renaissance of a syndrome. Clinical Endocrinology, 2007.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryCapsular Tear of the Metacarpophalangeal Joint
Pubic bone inflammation
Exhaustion Syndrome
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Secondary Hyperaldosteronism-en